KemPharm, Inc. KMPH
5.81 +5.81
Day range unavailable
52-week range unavailable
News
globenewswire.com Zevra Therapeutics to Report Fourth Quarter and Full-Year 2022 Results CELEBRATION, Fla., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: KMPH) (Zevra, or the Company, formerly KemPharm, Inc.), a rare disease therapeutics company, has announced…
seekingalpha.com KemPharm: Now A Rare Disease Play, Upgrading To A Buy Rating We initiated KemPharm with a Sell rating in March 2021; since then, the stock has declined >40%, and now the stock is trading at an attractive enterprise value of $130m. AZSTARYS targeting ADHD has…
benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022 Upgrades
seekingalpha.com KemPharm, Inc. (KMPH) Q3 2022 Earnings Call Transcript KemPharm, Inc. (NASDAQ:KMPH ) Q3 2022 Results Conference Call November 9, 2022 5:00 PM ET Company Participants Nichol Ochsner - Vice President of Investor Relations Travis Mickle - President and…
benzinga.com Earnings Scheduled For November 9, 2022 Companies Reporting Before The Bell • GCM Grosvenor (NASDAQ:GCMG) is likely to report quarterly earnings at $0.11 per share on revenue of $103.46 million.
zacks.com KemPharm (KMPH) Up On Positive Data From Sleep Disorder Study KemPharm (KMPH) reports positive top line from a study evaluating serdexmethylphenidate (SDX) for cardiovascular safety to progress the development of its prodrug KP1077.
benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2022 Upgrades
globenewswire.com KemPharm to Present at the H.C. Wainwright 24th Annual Global Investment Conference CELEBRATION, Fla., Sept. 01, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH) (KemPharm, or the Company), a specialty pharmaceutical company focused on the discovery, development and…
seekingalpha.com KemPharm, Inc. (KMPH) CEO Travis Mickle on Q2 2022 Results - Earnings Call Transcript KemPharm, Inc. (NASDAQ:KMPH ) Q2 2022 Earnings Conference Call August 11, 2022 5:00 PM ET Company Participants Nichol Ochsner - Vice President-Investor Relations & Corporate Communications Travis…
benzinga.com Earnings Scheduled For August 11, 2022 Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.
globenewswire.com KemPharm to Present at the Canaccord Genuity 42nd Annual Growth Conference CELEBRATION, Fla., Aug. 02, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH) (KemPharm, or the Company), a specialty pharmaceutical company focused on the discovery, development and…
globenewswire.com Orphazyme completes sale of substantially all of its assets and business activities to KemPharm Orphazyme A/SCompany announcement No. 29/2022 Inside information www.orphazyme.com Company Registration No. 32266355
zacks.com KemPharm (KMPH) Stock Up on Deal to Acquire Orphazyme for $12.8M KemPharm (KMPH) inks deal to acquire Orphazyme A/S, which will add to its portfolio the latter's pipeline candidate, arimoclomol, being developed for treating Niemann-Pick disease type C. Shares rise.
globenewswire.com Orphazyme A/S under In-Court-Restructuring to sell substantially all of its assets and business activities to KemPharm, Inc. Orphazyme A/S in restructuring Company announcement No. 24/2022Inside information www.orphazyme.com Company Registration No. 32266355
seekingalpha.com KemPharm, Inc. (KMPH) CEO Travis Mickle on Q1 2022 Results - Earnings Call Transcript KemPharm, Inc. (NASDAQ:KMPH ) Q1 2022 Earnings Conference Call May 12, 2022 5:00 PM ET Company Participants Travis Mickle - Co-Founder, President, CEO & Director LaDuane Clifton - CFO, Secretary &…
benzinga.com Earnings Scheduled For May 12, 2022 Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter.- benzinga.com 26 Stocks Moving in Monday's Pre-Market Session Gainers ERYTECH Pharma S.A. (NASDAQ: ERYP) shares rose 88.4% to $2.30 in pre-market trading. Erytech Pharma recently announced publication of results from Eryapasse Phase 2 trial as treatment for…
zacks.com KemPharm (KMPH) Starts Early-Stage Cardiovascular Safety Study KemPharm (KMPH) initiates dosing in a phase I study to evaluate the cardiovascular safety profile of its lead pipeline candidate, KP1077's sole active API, serdexmethylphenidate.
benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 466 companies hit new 52-week lows.
seekingalpha.com KemPharm, Inc. (KMPH) CEO Travis Mickle on Q4 2021 Results - Earnings Call Transcript KemPharm, Inc. (KMPH) CEO Travis Mickle on Q4 2021 Results - Earnings Call Transcript- benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 671 companies achieved new lows for the year.
globenewswire.com KemPharm to Report Fourth Quarter and Full-Year 2021 Results Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Wednesday, March 30, 2022, 5:00 p.m. ET
benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 524 stocks hit new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 313 companies hit new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 115 companies reached new 52-week lows.
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2022 Upgrades
benzinga.com KemPharm To Develop KP1077 As Lead SDX Candidate For Chronic Sleep Disorder KemPharm Inc (NASDAQ: KMPH) has selected KP1077 for idiopathic hypersomnia (IH) as its lead serdexmethylphenidate (SDX) candidate in the pipeline. Idiopathic hypersomnia is an uncommon sleep disorder…
globenewswire.com KemPharm to Host Investor Conference Call Detailing Plans for Pipeline Expansion Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Wednesday, January 19, 2022 at 4:30 p.m. ET
zacks.com Implied Volatility Surging for KemPharm (KMPH) Stock Options Investors need to pay close attention to KemPharm (KMPH) stock based on the movements in the options market lately.
seekingalpha.com KemPharm's (KMPH) CEO Travis Mickle on Q3 2021 Results - Earnings Call Transcript KemPharm's (KMPH) CEO Travis Mickle on Q3 2021 Results - Earnings Call Transcript- benzinga.com Earnings Scheduled For November 10, 2021 Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.24 per share on revenue of $94.32 million.
globenewswire.com KemPharm to Report Third Quarter 2021 Results Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Wednesday, November 10, 2021, 4:30 p.m. ET
globenewswire.com KemPharm, Inc. Announces Uplisting to The Nasdaq Global Select Market Trading to commence effective with the open of business on October 19, 2021- benzinga.com 78 Biggest Movers From Friday Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 43.4% to close at $3.27. PharmaCyte Biotech recently reported closing of $15-million public offering.
- benzinga.com Earnings Scheduled For August 12, 2021 Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter.
- benzinga.com Earnings Scheduled For May 13, 2021 Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million.
- benzinga.com Earnings Scheduled For March 11, 2021 Companies Reporting Before The Bell • Celsius Holdings (NASDAQ:CELH) is estimated to report quarterly earnings at $0.02 per share on revenue of $34.63 million.
- benzinga.com 82 Biggest Movers From Yesterday Gainers Five Prime Therapeutics, Inc. (NASDAQ: FPRX) shares surged 78.7% to close at $38.00 on Thursday after Amgen announced plans to acquire the company for $1.9 billion.
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For March 4, 2021
- benzinga.com Stocks That Hit 52-Week Highs On Wednesday On Wednesday morning, 198 companies hit new 52-week highs.
- benzinga.com Stocks That Hit 52-Week Highs On Wednesday This morning 533 companies reached new 52-week highs.
benzinga.com Stocks That Hit 52-Week Highs On Monday Monday morning saw 558 companies set new 52-week highs.- benzinga.com Stocks That Hit 52-Week Highs On Monday During the morning session on Monday, 372 stocks hit new 52-week highs.
benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For January 25, 2021 - benzinga.com Stocks That Hit 52-Week Highs On Monday This morning 127 companies reached new 52-week highs.
- benzinga.com Earnings Scheduled For August 12, 2020 Companies Reporting Before The Bell • Brinker International Inc. (NYSE:EAT) is expected to report quarterly loss at $1.43 per share on revenue of $571.05 million.
- benzinga.com Stocks That Hit 52-Week Lows On Monday
- benzinga.com 50 Stocks Moving In Tuesday's Mid-Day Session
- benzinga.com Stocks That Hit 52-Week Lows On Thursday
- benzinga.com The Daily Biotech Pulse: Qiagen Opts To Stay Solo Following Strategic Review, Spectrum Slumps On Negative Data, Microbot Medical To Offer Shares